Angarayngay, Daryl Jane S.
HRN: 28-52-65 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/18/2026
CO-AMOXICLAV 625MG (TAB)
02/18/2026
02/24/2026
PO
625
Q8h
SP NSVD; Leukocytosis
Checking Initial Appropriateness